Education
About Us
Working with TipRanks
Follow Us
Veeva Systems (VEEV)
NYSE:VEEV
VEEV Analyst Ratings
Moderate Buy
16 Buy
5 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
VEEV Stock 12 Month Forecast
Average Price Target
$322.78
▲(6.95% Upside)
| Highest Price Target$380.00 | Average Price Target$322.78 | Lowest Price Target$222.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
$297→$380
Buy
25.91%
Upside
Upgraded
10/07/25
Veeva Systems Poised for Growth: Buy Rating Affirmed Amid CRM Success and Industry TrendsWe upgrade VEEV to Buy from Hold, as we believe VEEV is well positioned to see topline growth above current cons. est. due to multiple drivers: 1) de-risked CRM replatforming; 2) secular shift to 3) IQV partnership removing lingering overhang and expanding new oppys. We expect VEEV shares to re- rate moving fwd (tgt. EV/'27FCF multiple of 31x vs. current 24x multiple).
RBC Capital
―
Buy
―
Reiterated
10/03/25
Truist Financial
―
Hold
―
Reiterated
09/24/25
Stifel Nicolaus
$295→$320
Buy
6.03%
Upside
Reiterated
09/22/25
TR | OpenAI - 4o
$310→$317
Buy
5.04%
Upside
Reiterated
09/19/25
AI Generated ArticleAI Generated Article
Raymond James
―
Buy
―
Reiterated
09/10/25
Veeva Systems: Strategic Positioning and Growth Potential Justify Buy RatingWe still feel that Salesforce has likely gained some mind share with its Agentforce offering, particularly for heavily customized pharma sales organizations. That said, we also believe Veeva’s growing drumbeat on embedded verticalized agents offers customers comfort that the company will continue to drive innovation within life sciences. SEPTEMBER 10, 2025 | 10:42 AM EDT COMPANY BRIEF MA/ACC MARKET DATA Cap (mln) $47,872 Current Net Debt (mln) $(6,318) Enterprise Value (mln) $41,554 Shares Outstanding (mln) 172.5 30-Day Avg.
Exane BNP Paribas
$320
Buy
6.03%
Upside
Reiterated
09/10/25
J.P. Morgan
$290→$330
Buy
9.34%
Upside
Upgraded
09/08/25
Citi
$329→$349
Buy
15.64%
Upside
Reiterated
08/29/25
Barclays
$300→$325
Buy
7.69%
Upside
Reiterated
08/28/25
UBS
$285→$310
Hold
2.72%
Upside
Reiterated
08/28/25
Oppenheimer
$325
Buy
7.69%
Upside
Reiterated
08/28/25
Evercore ISI
$285→$295
Hold
-2.25%
Downside
Reiterated
08/28/25
William Blair
―
Buy
―
Reiterated
08/28/25
Needham
$300→$355
Buy
17.63%
Upside
Reiterated
08/28/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
$297→$380
Buy
25.91%
Upside
Upgraded
10/07/25
Veeva Systems Poised for Growth: Buy Rating Affirmed Amid CRM Success and Industry TrendsWe upgrade VEEV to Buy from Hold, as we believe VEEV is well positioned to see topline growth above current cons. est. due to multiple drivers: 1) de-risked CRM replatforming; 2) secular shift to 3) IQV partnership removing lingering overhang and expanding new oppys. We expect VEEV shares to re- rate moving fwd (tgt. EV/'27FCF multiple of 31x vs. current 24x multiple).
RBC Capital
―
Buy
―
Reiterated
10/03/25
Truist Financial
―
Hold
―
Reiterated
09/24/25
Stifel Nicolaus
$295→$320
Buy
6.03%
Upside
Reiterated
09/22/25
TR | OpenAI - 4o
$310→$317
Buy
5.04%
Upside
Reiterated
09/19/25
AI Generated ArticleAI Generated Article
Raymond James
―
Buy
―
Reiterated
09/10/25
Veeva Systems: Strategic Positioning and Growth Potential Justify Buy RatingWe still feel that Salesforce has likely gained some mind share with its Agentforce offering, particularly for heavily customized pharma sales organizations. That said, we also believe Veeva’s growing drumbeat on embedded verticalized agents offers customers comfort that the company will continue to drive innovation within life sciences. SEPTEMBER 10, 2025 | 10:42 AM EDT COMPANY BRIEF MA/ACC MARKET DATA Cap (mln) $47,872 Current Net Debt (mln) $(6,318) Enterprise Value (mln) $41,554 Shares Outstanding (mln) 172.5 30-Day Avg.
Exane BNP Paribas
$320
Buy
6.03%
Upside
Reiterated
09/10/25
J.P. Morgan
$290→$330
Buy
9.34%
Upside
Upgraded
09/08/25
Citi
$329→$349
Buy
15.64%
Upside
Reiterated
08/29/25
Barclays
$300→$325
Buy
7.69%
Upside
Reiterated
08/28/25
UBS
$285→$310
Hold
2.72%
Upside
Reiterated
08/28/25
Oppenheimer
$325
Buy
7.69%
Upside
Reiterated
08/28/25
Evercore ISI
$285→$295
Hold
-2.25%
Downside
Reiterated
08/28/25
William Blair
―
Buy
―
Reiterated
08/28/25
Needham
$300→$355
Buy
17.63%
Upside
Reiterated
08/28/25
Best Analysts Covering Veeva Systems
1 Month
xxx
Success Rate
12/18 ratings generated profit
Average Return
+2.91%
reiterated a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.91% per trade.
3 Months
xxx
Success Rate
18/26 ratings generated profit
Average Return
+8.27%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.23% of your transactions generating a profit, with an average return of +8.27% per trade.
1 Year
Success Rate
18/18 ratings generated profit
Average Return
+23.45%
reiterated a buy rating last month
Copying Stan Berenshteyn's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +23.45% per trade.
2 Years
xxx
Success Rate
24/24 ratings generated profit
Average Return
+39.11%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +39.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
VEEV Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
28
30
34
35
30
Hold
11
11
12
11
10
Sell
2
1
2
2
2
Strong Sell
0
0
0
0
0
total
41
42
48
48
42
Each month's total comprises the sum of three months' worth of ratings.
VEEV Financial Forecast
VEEV Stock Forecast FAQ
What is VEEV’s average 12-month price target, according to analysts?
Based on analyst ratings, Veeva Systems’s 12-month average price target is 322.78.
What is VEEV’s upside potential, based on the analysts’ average price target?
Veeva Systems has 6.95% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is VEEV a Buy, Sell or Hold?
Veeva Systems has a consensus rating of Moderate Buy which is based on 16 buy ratings, 5 hold ratings and 1 sell ratings.
What is Veeva Systems’s price target?
The average price target for Veeva Systems is 322.78. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $380.00 ,the lowest forecast is $222.00. The average price target represents 6.95% Increase from the current price of $301.8.
The highest analyst price target is $380.00 ,the lowest forecast is $222.00. The average price target represents 6.95% Increase from the current price of $301.8.
What do analysts say about Veeva Systems?
Veeva Systems’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.
How can I buy shares of VEEV?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.